Regulatory authorities in two countries have given the green light for clinical testing of a novel treatment from Mabwell Bioscience — which the company…
Myeloma
I find myself watching my mother’s hands more often these days. It shouldn’t come as a surprise, though. After all, observation is one of…
A protein called IRF2 may help drive myeloma, and measuring its levels could help predict outcomes among people with the blood cancer, a new…
Some nights I sit beside my mum’s bed and look back on the four years since her myeloma diagnosis. I find it hard to…
U.S. authorities have granted a permanent billing code for Blenrep (belantamab mafodotin), an approved treatment for certain adults with hard-to-treat multiple myeloma., a…
A regulatory committee in the European Union has recommended expanding approval of a dual regimen for hard-to-treat myeloma —…
Note: This column describes the author’s own thoughts about GLP-1 agonist medications. Not everyone will have the same response to treatment. Consult your doctor before…
Some mornings the mirror catches me off guard. I know this might sound strange, especially when one is new to caregiving. But I haven’t just…
Adults in the U.S. now have a new generic drug option — Bortezomib for Injection, an equivalent of the approved medication Velcade (bortezomib) —…
Before I got multiple myeloma, I didn’t think much about health insurance. I didn’t even have health insurance 40 years ago! I was young…
Recent Posts
- Regulators in 2 countries OK clinical testing of new blood cancer treatment
- The changing details of my mother’s hands tell her life story
- Glioblastoma trial adds new drug in search for better treatments
- Protein marker may help predict myeloma outcomes
- What I’ve learned about endurance since my mum’s myeloma diagnosis
